About Us

OTA ProcessThe mission of the NYU Office of Therapeutics Alliances is to provide a continuum of resources to develop and advance NYU research projects, thereby increasing their appeal to commercial and financial partners. OTA aims to accelerate NYU translational research focused on development of potential new therapeutics, and to “de-risk” innovative NYU projects to facilitate drug discovery alliances with pharma, biotech, investors, federal granting sources, nonprofits and foundations. OTA utilizes both internal and external capabilities to fund and manage key activities in therapeutics discovery and early stage development, including target validation, small molecule library screening, hit-to-lead medicinal chemistry optimization, animal toxicology and pharmacokinetics. Operating in a flexible and cost-conscious manner, OTA collaborates with multiple stakeholders to increase the creation and value of novel, NYU-derived therapeutics.